AdvaGen’s generics strategy combines incremental innovation and efficient execution to achieve high ROI. 13 NDA’s and 65+ ANDAs listed on the US FDA’s Orange Book with a track record of successfully commercializing over 85% approvals. Strong customer relationships built on consistent supplies and best-in-class OTIF performance. Ranked in top 3 by market share in 13 products, 6 products with more than 25% market share. Incessant focus on supply chain (dual+ sourced API, 3PL, In-house Distribution. | AdvaGen Pharma is a dependable source of high-quality generic medicines for retail chains, wholesalers, and GPOs across the United States. Our portfolio includes 275+ NDCs across 13+ NDAs and 75+ ANDAs listed in the FDA Orange Book, with a track record of successfully commercializing 93% of approvals. We build long-term partnerships through competitive pricing, responsive contracting, and best-in-class OTIF performance, supported by dual-plus sourced API, 3PL infrastructure, and in-house distribution. Our strategy combines incremental innovation with efficient execution to deliver strong support for our customers. From routine fill to new product launches, AdvaGen is the supplier chain drug stores count on when consistency, availability, and service matter most.
AbbVie US LLC (AbbVie)
AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. AbbVie is committed to using unique approaches to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.